Sana Biotechnology, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA,
Mailing Address
188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA,
Phone
(206) 701-7914
Fiscal Year End
1231
EIN
831381173
Financial Overview
FY2025
$256.01M
Total Liabilities
$-0.96
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 8, 2026 | View on SEC |
| 3 Initial insider ownership report | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 10-K Annual financial report | March 3, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 3 Initial insider ownership report | February 18, 2026 | View on SEC |
Annual Reports
10-K
March 3, 2026
- Initiated a Phase 1 clinical trial for its lead *in vivo* gene therapy candidate, SC291, with initial patient dosing expected in early 2026.
- Filed an Investigational New Drug (IND) application for its first hypoimmune cell therapy candidate, SC451, for oncology applications, paving the way for potential clinical trials in 2026.
Related Companies
Companies in the same industry (SIC: 2836)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Vaxcyte, Inc.
PCVX
Biological Products, (No Diagnostic Substances)
RECURSION PHARMACEUTICALS, INC.
RXRX
Biological Products, (No Diagnostic Substances)
MeiraGTx Holdings plc
MGTX
Biological Products, (No Diagnostic Substances)
Ginkgo Bioworks Holdings, Inc.
DNA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.